Concepedia

Terry Furlong

TF

14

Publications

1.3K

Citations

14

H-Index

2000

Active since

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Cancer Research Center

The University of Texas MD Anderson Cancer Center

Terry Furlong is an author at Fred Hutch Cancer Center specializing in pharmacotherapy, immunology, and hematology.

Top concepts

Publications per year

2000–2017

14

Publications

14

Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

Christopher G. Kanakry, Paul V. O’Donnell, Terry Furlong et al. · Journal of Clinical Oncology · 2014 · 271 citations · Full text

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation

Marco Mielcarek, Terry Furlong, Paul V. O’Donnell et al. · Blood · 2016 · 225 citations · Full text

SIROLIMUS (RAPAMYCIN) FOR THE TREATMENT OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE1

Ana Benito, Terry Furlong, Paul J. Martin et al. · Transplantation · 2001 · 182 citations

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes

Marco Mielcarek, Barry E. Storer, Michael Boeckh et al. · Blood · 2008 · 136 citations · Full text

A Phase I/II Study of Mycophenolate Mofetil in Combination with Cyclosporine for Prophylaxis of Acute Graft-versus-Host Disease after Myeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation

Richard A. Nash, Laura Johnston, Pablo Parker et al. · Biology of Blood and Marrow Transplantation · 2005 · 124 citations

Rows per page

1–5 of 14